Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.5110 -0.0443 (-7.98%)
Streaming Delayed Price Updated: 1:46 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
From Gossamer Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
From Gossamer Bio, Inc.
Via Business Wire
News headline image
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
GOSS Stock Earnings: Gossamer Bio Meets EPS for Q4 2023 ↗
GOSS stock results show that Gossamer Bio met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
7 Micro-Cap Stocks That Could Majorly Surprise Investors ↗
Although extremely small enterprises can be terrifyingly risky, these micro-cap stock surprises deserve a closer look. 
Via InvestorPlace
News headline image
Recap: Gossamer Bio Q3 Earnings ↗
 
Via Benzinga
News headline image
Analyst Expectations for Gossamer Bio's Future ↗
 
Via Benzinga
News headline image
Analyst Ratings for Gossamer Bio ↗
 
Via Benzinga
News headline image
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
From Gossamer Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
From Gossamer Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying ↗
The Dow Jones closed higher by around 490 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results
From Gossamer Bio, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.